Diaverum

At Diaverum, we are at the forefront of revolutionizing renal care through groundbreaking technology and a steadfast commitment to patient-centric innovation. Our mission is to enhance the lives of individuals suffering from chronic kidney disease by providing them with world-class medical services that are not only life-sustaining but also life-enriching. Founded in 1991 as part of Gambro, our journey has been one of continuous advancement, evolving into a leading global provider of renal care services. We leverage cutting-edge digital health solutions and artificial intelligence to deliver personalized and preventative care. A prime example of our innovative spirit is the development of a proprietary AI model designed to predict vascular access thrombosis, a significant complication for hemodialysis patients. This predictive capability allows for early intervention, drastically reducing patient suffering and mortality rates, and showcasing our dedication to leveraging technology for superior medical outcomes.

Our holistic approach to renal care extends beyond dialysis. We offer a comprehensive portfolio of services including preventive care, peritoneal dialysis, home care, and the management of patient comorbidities. This integrated model is supported by a robust digital infrastructure, including our d.CARE patient app, which empowers individuals by giving them access to their treatment data and enabling them to actively participate in their own care. As part of the M42 group, we are further empowered to advance health innovation on a global scale, combining our specialized expertise with M42's prowess in AI, genomics, and technology. We are committed to expanding access to the highest quality of care, continually pushing the boundaries of what's possible in renal medicine. Our vision is to transform the industry, making personalized, life-enhancing care a reality for patients worldwide, ensuring they can lead fulfilling lives despite their condition.